Cancer, Treatment-Related
Conditions
Brief summary
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.
Interventions
OTHERVisits conducted via Telemedicine
Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse
Sponsors
Grand River Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide. 2. Ability to provide consent to study. 3. Willingness to complete study questionnaires and a semi-structured exit interview. 4. Adequate command of the English language to complete study questionnaire and survey. 5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group) 6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group)
Exclusion criteria
1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide. 2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group) \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction with overall care | 2 Years | The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC |
Countries
Canada
Contacts
Primary ContactStacey Hubay, MD, FRCPC
Backup ContactCarla Girolametto, MA, MHSC
Outcome results
None listed